Search research articles
Contact Us
Filters
Showing results (871-880 of 921) with videos related to
Page
of 93
Sort By:
The Journal of Investigative Dermatology
|
June 8, 2007
Multiple self-healing squamous epithelioma in different ethnic groups: more than a founder mutation disorder?
Mariella D'Alessandro, Stephanie E Coats, Susan M Morley, et al.
Biorxiv : the Preprint Server for Biology
|
April 15, 2024
Distinct genomic and immunologic tumor evolution in germline <i>TP53</i>-driven breast cancers
Nabamita Boruah, David Hoyos, Renyta Moses, et al.
Nature Communications
|
May 21, 2026
Distinct genomic and immunologic tumor evolution in germline TP53-driven breast cancers
Nabamita Boruah, David Hoyos, Renyta Moses, et al.
Leukemia
|
June 13, 2008
On the use of lonafarnib in myelodysplastic syndrome and chronic myelomonocytic leukemia
E J Feldman, J Cortes, D J DeAngelo, et al.
Molecular Cancer Therapeutics
|
May 6, 2015
Protein Phosphatase 2A Inhibition with LB100 Enhances Radiation-Induced Mitotic Catastrophe and Tumor Growth Delay in Glioblastoma
Ira K Gordon, Jie Lu, Christian A Graves, et al.
Blood
|
September 26, 2007
Phase 2 study of lenalidomide in transfusion-dependent, low-risk, and intermediate-1 risk myelodysplastic syndromes with karyotypes other than deletion 5q
Azra Raza, James A Reeves, Eric J Feldman, et al.
Molecular Cancer Therapeutics
|
November 17, 2017
Characterization of SGN-CD123A, A Potent CD123-Directed Antibody-Drug Conjugate for Acute Myeloid Leukemia
Fu Li, May Kung Sutherland, Changpu Yu, et al.
Journal of Burn Care & Research : Official Publication of the American Burn Association
|
May 26, 2018
A Comparative Study of the ReCell® Device and Autologous Spit-Thickness Meshed Skin Graft in the Treatment of Acute Burn Injuries
James Hill Holmes Iv, Joseph A Molnar, Jeffrey E Carter, et al.
Blood
|
October 24, 2002
Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)
John C Byrd, Krzysztof Mrózek, Richard K Dodge, et al.
Chest
|
September 9, 2021
Mass Critical Care Surge Response During COVID-19: Implementation of Contingency Strategies - A Preliminary Report of Findings From the Task Force for Mass Critical Care
Jeffrey R Dichter, Asha V Devereaux, Charles L Sprung, et al.
Page
of 93
Search research articles
Search
Showing results (871-880 of 921) with videos related to
Sort By:
Page
of 93
The Journal of Investigative Dermatology
|
June 8, 2007
Multiple self-healing squamous epithelioma in different ethnic groups: more than a founder mutation disorder?
Mariella D'Alessandro, Stephanie E Coats, Susan M Morley, et al.
Biorxiv : the Preprint Server for Biology
|
April 15, 2024
Distinct genomic and immunologic tumor evolution in germline <i>TP53</i>-driven breast cancers
Nabamita Boruah, David Hoyos, Renyta Moses, et al.
Nature Communications
|
May 21, 2026
Distinct genomic and immunologic tumor evolution in germline TP53-driven breast cancers
Nabamita Boruah, David Hoyos, Renyta Moses, et al.
Leukemia
|
June 13, 2008
On the use of lonafarnib in myelodysplastic syndrome and chronic myelomonocytic leukemia
E J Feldman, J Cortes, D J DeAngelo, et al.
Molecular Cancer Therapeutics
|
May 6, 2015
Protein Phosphatase 2A Inhibition with LB100 Enhances Radiation-Induced Mitotic Catastrophe and Tumor Growth Delay in Glioblastoma
Ira K Gordon, Jie Lu, Christian A Graves, et al.
Blood
|
September 26, 2007
Phase 2 study of lenalidomide in transfusion-dependent, low-risk, and intermediate-1 risk myelodysplastic syndromes with karyotypes other than deletion 5q
Azra Raza, James A Reeves, Eric J Feldman, et al.
Molecular Cancer Therapeutics
|
November 17, 2017
Characterization of SGN-CD123A, A Potent CD123-Directed Antibody-Drug Conjugate for Acute Myeloid Leukemia
Fu Li, May Kung Sutherland, Changpu Yu, et al.
Journal of Burn Care & Research : Official Publication of the American Burn Association
|
May 26, 2018
A Comparative Study of the ReCell® Device and Autologous Spit-Thickness Meshed Skin Graft in the Treatment of Acute Burn Injuries
James Hill Holmes Iv, Joseph A Molnar, Jeffrey E Carter, et al.
Blood
|
October 24, 2002
Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)
John C Byrd, Krzysztof Mrózek, Richard K Dodge, et al.
Chest
|
September 9, 2021
Mass Critical Care Surge Response During COVID-19: Implementation of Contingency Strategies - A Preliminary Report of Findings From the Task Force for Mass Critical Care
Jeffrey R Dichter, Asha V Devereaux, Charles L Sprung, et al.
Page
of 93